PH 2 Pemigatinib in SDH-deficient GIST

Abroad (travel likely)RecruitingPHASE2

Conditions

SDH Gene Mutation · Gastrointestinal Stromal Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Suzanne George, MD) · 877-338-7425
Contact: Principal Investigator (Suzanne George, MD)

Study leads

Suzanne George, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

Gastric Cancer · Gastric Neoplasm · Gastrointestinal Stromal Sarcoma

Abroad (travel likely)Recruiting

Bethesda, United States

Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers

SDH-Related Familial Paraganglioma · SDHx-Related Syndromes · SDH Gene Mutation

Abroad (travel likely)Recruiting

Angers, France · Besançon, France